Top

Published in:

Open Access 01-05-2009 | original article

Local Treatment for Recurrent Colorectal Hepatic Metastases after Partial Hepatectomy

Authors: Anne E. M. van der Pool, Z. S. Lalmahomed, Johannes H. W. de Wilt, Alexander M. M. Eggermont, Jan M. N. IJzermans, Cornelis Verhoef

Published in: Journal of Gastrointestinal Surgery | Issue 5/2009

Abstract

Objective

The objective of the study was to identify patients who may benefit from local treatment in recurrent colorectal liver metastases.

Materials and methods

A total of 51 consecutive patients were treated for hepatic recurrence(s) after an initial partial hepatic resection. Surgery was considered as the primary treatment option for eligible patients. Patients with a small liver remnant after major hepatectomy were treated with radiofrequency ablation (RFA) or stereotactic body radiation therapy (SRx). SRx was given as an outpatient, emerging local treatment option for patients with intra-hepatic recurrences not eligible for surgery or RFA. Partial liver resection was performed in 36 patients (70%), RFA in ten patients (20%), and SRx in five patients (10%).

Results

Median hospital stay was 7 (range, 3–62) days with a morbidity of 16% without in-hospital death. None of the patients received adjuvant chemotherapy. There was no difference in recurrence or survival between the three treatment modalities. Overall 5-year survival was 35% with an estimated median survival of 37 months. Patients with a disease-free interval between first hepatectomy and hepatic recurrence less than 6 months did not survive 3 years.

Conclusions

Resection, RFA, and SRx can be performed safely in patients with recurrent colorectal liver metastases and offer a survival that seems comparable to primary liver resections of colorectal liver metastases.

Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19(1):59–71. doi:10.1007/BF00316981.PubMedCrossRef

Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343(8910):1405–1410. doi:10.1016/S0140-6736(94)92529-1.PubMedCrossRef

Simmonds PC, Primrose JN, Colquitt JL et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006;94(7):982–999. doi:10.1038/sj.bjc.6603033.PubMedCrossRef

Adam R, Bismuth H, Castaing D et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg 1997;225(1):51–60. discussion 60–2. doi:10.1097/00000658-199701000-00006.PubMedCrossRef

Petrowsky H, Gonen M, Jarnagin W et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 2002;235(6):863–871. doi:10.1097/00000658-200206000-00015.PubMedCrossRef

Shaw IM, Rees M, Welsh FK et al. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg 2006;93(4):457–464. doi:10.1002/bjs.5323.PubMedCrossRef

Sugarbaker PH. Repeat hepatectomy for colorectal metastases. J Hepatobiliary Pancreat Surg 1999;6(1):30–38. doi:10.1007/s005340050081.PubMedCrossRef

Thelen A, Jonas S, Benckert C et al. Repeat liver resection for recurrent liver metastases from colorectal cancer. Eur J Surg Oncol 2007;33(3):324–328. doi:10.1016/j.ejso.2006.10.016.PubMedCrossRef

Yamamoto J, Kosuge T, Shimada K et al. Repeat liver resection for recurrent colorectal liver metastases. Am J Surg 1999;178(4):275–281. doi:10.1016/S0002-9610(99)00176-2.PubMedCrossRef

10.

de Meijer VE, Verhoef C, Kuiper JW et al. Radiofrequency ablation in patients with primary and secondary hepatic malignancies. J Gastrointest Surg 2006;10(7):960–973. doi:10.1016/j.gassur.2006.03.003.PubMedCrossRef

11.

Mendez Romero A, Wunderink W, van Os RM et al. Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors. Int J Radiat Oncol Biol Phys 2008;70(5):1447–1452.PubMed

12.

Tournigand C, Andre T, Achille E et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004;22(2):229–237. doi:10.1200/JCO.2004.05.113.PubMedCrossRef

13.

Zampino MG, Magni E, Massacesi C et al. First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer. Cancer 2007;110(4):752–758. doi:10.1002/cncr.22851.PubMedCrossRef

14.

Curley SA. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol 2008;15(1):11–13. doi:10.1245/s10434-007-9668-1.PubMedCrossRef

15.

de Meijer VE, Ijzermans JN, Verhoef C. A place for radiofrequency ablation in the treatment of resectable colorectal liver metastases? Ann Surg Oncol 2008;15(7):2063. doi:10.1245/s10434-008-9843-z author reply 2064–5.PubMedCrossRef

16.

Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg 1999;16(6):459–467. doi:10.1159/000018770.PubMedCrossRef

17.

McMillan DC, McArdle CS. Epidemiology of colorectal liver metastases. Surg Oncol 2007;16(1):3–5. doi:10.1016/j.suronc.2007.04.008.PubMedCrossRef

18.

Falcone A, Ricci S, Brunetti I et al. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 2007;25(13):1670–1676. doi:10.1200/JCO.2006.09.0928.PubMedCrossRef

19.

Dols LF, Verhoef C, Eskens FA, Schouten O, Nonner J, Hop WC, Méndez Romero A, De Man RA Van der Linden, Dwarkasing R, IJzermans JN. Improvement of survival after resection of colorectal liver metastases. Ned Tijdschr Geneeskd. 2008; in press.

20.

DeMatteo RP, Fong Y, Jarnagin WR, Blumgart LH. Recent advances in hepatic resection. Semin Surg Oncol 2000;19(2):200–207. doi:10.1002/1098-2388(200009)19:2<200::AID-SSU11>3.0.CO;2-M.PubMedCrossRef

21.

Jarnagin WR, Gonen M, Fong Y et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002;236(4):397–406. doi:10.1097/00000658-200210000-00001 discussion 406–7.PubMedCrossRef

22.

Are C, Gonen M, Zazzali K et al. The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg 2007;246(2):295–300. doi:10.1097/SLA.0b013e31811ea962.PubMedCrossRef

23.

Figueras J, Burdio F, Ramos E et al. Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol 2007;18(7):1190–1195. doi:10.1093/annonc/mdm106.PubMedCrossRef

24.

Pawlik TM, Scoggins CR, Zorzi D et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241(5):715–722. doi:10.1097/01.sla.0000160703.75808.7d discussion 722–4.PubMedCrossRef

25.

Pawlik TM, Vauthey JN. Surgical margins during hepatic surgery for colorectal liver metastases: complete resection not millimeters defines outcome. Ann Surg Oncol 2008;15(3):677–679. doi:10.1245/s10434-007-9703-2.PubMedCrossRef

26.

Zorzi D, Mullen JT, Abdalla EK et al. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 2006;10(1):86–94. doi:10.1016/j.gassur.2005.07.022.PubMedCrossRef

27.

Bhattacharjya S, Aggarwal R, Davidson BR. Intensive follow-up after liver resection for colorectal liver metastases: results of combined serial tumour marker estimations and computed tomography of the chest and abdomen—a prospective study. Br J Cancer 2006;95(1):21–26. doi:10.1038/sj.bjc.6603219.PubMedCrossRef

28.

Benoist S, Pautrat K, Mitry E et al. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005;92(9):1155–1160. doi:10.1002/bjs.5060.PubMedCrossRef

29.

Sutherland LM, Williams JA, Padbury RT et al. Radiofrequency ablation of liver tumors: a systematic review. Arch Surg 2006;141(2):181–190. doi:10.1001/archsurg.141.2.181.PubMedCrossRef

30.

Katz AW, Carey-Sampson M, Muhs AG et al. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 2007;67(3):793–798. doi:10.1016/j.ijrobp.2006.10.025.PubMed

31.

Mulier S, Ni Y, Jamart J et al. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol 2008;15(1):144–157. doi:10.1245/s10434-007-9478-5.PubMedCrossRef

Title: Local Treatment for Recurrent Colorectal Hepatic Metastases after Partial Hepatectomy
Authors: Anne E. M. van der Pool
Z. S. Lalmahomed
Johannes H. W. de Wilt
Alexander M. M. Eggermont
Jan M. N. IJzermans
Cornelis Verhoef
Publication date: 01-05-2009
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 5/2009
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-008-0794-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Local Treatment for Recurrent Colorectal Hepatic Metastases after Partial Hepatectomy

Abstract

Objective

Materials and methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2009

CT Findings in Diffuse Rectosigmoid Cavernous Heamangioma. A Case Report

Intraoperative Assessment of Pancreatic Neck Margin at the Time of Pancreaticoduodenectomy Increases Likelihood of Margin-Negative Resection in Patients with Pancreatic Cancer

Comparison of One-Stage Managements of Obstructing Left-Sided Colon and Rectal Cancer: Stent-Laparoscopic Approach vs. Intraoperative Colonic Lavage

Association of Gastroesophageal Reflux and O2 Desaturation: A Novel Study of Simultaneous 24-h MII–pH and Continuous Pulse Oximetry

MicroRNA-143 and -205 Expression in Neosquamous Esophageal Epithelium Following Argon Plasma Ablation of Barrett’s Esophagus

Cannabinoid Receptor-1 Blockade Attenuates Acute pancreatitis in Obesity by An adiponectin Mediated Mechanism